Engineering Conferences International

ECI Digital Archives
Cell Culture Engineering XV

Proceedings

Spring 5-10-2016

Scale-up and scale-down challenges for a high
density long-term perfusion suspension cell culture
in large-scale single use bioreactors
Weichang Zhou
WuXi AppTec Co., Ltd,, weichang_zhou@wuxiapptec.com

Hang Zhou
WuXi AppTec

Follow this and additional works at: http://dc.engconfintl.org/cellculture_xv
Part of the Biomedical Engineering and Bioengineering Commons
Recommended Citation
Weichang Zhou and Hang Zhou, "Scale-up and scale-down challenges for a high density long-term perfusion suspension cell culture in
large-scale single use bioreactors" in "Cell Culture Engineering XV", Robert Kiss, Genentech Sarah Harcum, Clemson University Jeff
Chalmers, Ohio State University Eds, ECI Symposium Series, (2016). http://dc.engconfintl.org/cellculture_xv/27

This Abstract is brought to you for free and open access by the Proceedings at ECI Digital Archives. It has been accepted for inclusion in Cell Culture
Engineering XV by an authorized administrator of ECI Digital Archives. For more information, please contact franco@bepress.com.

Scale-up and scale-down challenges for a high density long-term perfusion
suspension cell culture in large-scale single use bioreactors
Weichang Zhou and Hang Zhou, Biologics and Bioprocess, WuXi AppTec Co., Ltd,
Shanghai, China 200131, weichang_zhou@wuxiapptec.com
As part of efforts to develop a continuous processing platform for biologics
manufacturing using single use bioreactors, we have been focusing on development of
several initial unit operations: high density perfusion suspension cell cultures and
early product capture steps, in order to realize its potentials of being flexible,
improving product quality and lowering costs. These initial unit operations require
large volumes and represent the most important part of this processing platform. By
integrating these steps into a continuous operation, we can deliver the largest benefits
of this processing platform. In this presentation, we will discuss our efforts towards
continuous biologics manufacturing using a case study focusing on direct scale-up of
an ATF (Alternating Tangential Flow) based high density perfusion cell culture, from
2L scale coupled with ATF2 to large single use bioreactors coupled with ATF6 or
ATF10. Appropriate considerations of agitation and aeration rates, ATF operation
parameters as well as bioreactor processing conditions resulted in successful scale-up
of more than 100 folds. This high density long-term perfusion suspension cell culture
was successfully implemented in large scale single use bioreactors. Results of largescale manufacturing batches indicate highly consistent process performance,
productivity and quality of directly captured products. Furthermore, a representative
scale-down model based on ATF2 was established for manufacturing support and
further process optimization.

